Is Citrus Flavonoids Blood Pressure Meta-Analysis safe?

The current Migaku evidence database contains 2 reusable source documents for Citrus Flavonoids Blood Pressure Meta-Analysis. This answer focuses on safety, limits, and clinician-discussion contexts. - Genetic factors, dietary habits, and lifestyle may influence individual responses to supplementation, including the bergamot flavanones naringin and naringenin, which are implicated in lipid modulation. [Yu X (2026); evidence level 2] - The aim of this double-blind, placebo-controlled clinical trial (RCT) is to assess the effects of the supplementation for four months of a standardised bergamot extract at the dosage of 375 mg/day, providing 150 mg/day of flavonoids, on lipid parameters of 108 East Asian adults with LDL-Cholesterol (LDL-C) 100-159 mg/day, since to date, the RCTs have been conducted on Caucasian subjects only. [Yu X (2026); evidence level 2] - The increasing burden is largely driven by metabolic risk factors such as hypertension, obesity, dyslipidemia, and impaired glucose regulation, reflecting the ongoing global rise in metabolic disorders []. [Doaei Saeid (2026); evidence level 3] - Environmental and lifestyle factors, including diet quality and intake of bioactive dietary components, are increasingly recognized as major contributors to cardiometabolic risk []. [Doaei Saeid (2026); evidence level 3] - These compounds may influence gene expression through epigenetic mechanisms and have been associated with the prevention of cardiometabolic diseases [,]. [Doaei Saeid (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.